mesa redonda: medicamentos de alto costo - argentina · mesa redonda: medicamentos de alto costo....
TRANSCRIPT
![Page 1: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/1.jpg)
Héctor Pérez
Mesa redonda:Medicamentos de alto costo
![Page 2: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/2.jpg)
The Costs of Cancer Treatment
![Page 3: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/3.jpg)
Growth in Cost of Oncology
Therapeutics, US
IQVIA, MIDAS Q4 2016; IQVIA Institute for Human Data Science, March 2017. Slide credit: clinicaloptions.com
0
5
10
15
20
25
30
35
40
45
50
2011 New
Therapies
Since 2011
Branded
Volume
Branded
Price
LOE Generics 2016
23.4
13.6
3.4
5.8 -4.8 2.6
44.1
Costs
and G
row
th
![Page 4: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/4.jpg)
Where Will Cost Control Come From?
ACCC. 2017 Trending Now in Cancer Care Survey. Slide credit: clinicaloptions.com
Which of the
following are
your cancer
program’s
biggest
opportunities for
cost savings?
‒ 62%
identified
drugs as the
biggest
opportunity
Clinical standardization
Clinical staff
Technology maintenance
Nonclinical staff (eg, financial counselor, schedulers)
Capital expenses (eg, LINAC, imaging technology)
Supplies
Drugs
Support services (eg, yoga, acupuncture,
nutrition)
Clinical research
Retail pharmacy
Other
63%
62%
28%
24%
22%
20%
16%
14%
10%
9%
4%
![Page 5: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/5.jpg)
Actualización en Hepatitis CAsesoría Médico/Bioquímica
Héctor Pérez
SubGerencia Médica de Gestión
Dirección Médica
![Page 6: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/6.jpg)
HCV in the US: Gaps in Current Practice
Pts
(%
)
n = 3,500,000 1,743,000 1,514,667 952,726 581,632 555,883 326,859
0
20
40
60
80
100
ChronicHCV
Infected
Diagnosedand
Aware
Access to
Care
HCV RNAConfirmed
Liver Biopsy
Prescribed HCV
Treatment
AchievedSVR
100%
50%
43%
27%
17% 16%9%
Yehia BR, et al. PLoS One. 2014;9:e101554.
![Page 7: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/7.jpg)
References in slidenotes.
IFN6 Mos
PegIFN/ RBV
12 Mos
IFN12 Mos
IFN/RBV12 Mos
PegIFN12 Mos
2001
1998
2011
StandardInterferon
Ribavirin
Peginterferon
1991
PegIFN/RBV +DAA
IFN/RBV6 Mos
6
16
3442 39
55
70+
0
20
40
60
80
100
DAA + RBV ±PegIFN
90+2013
All–OralDAA±
RBV
Current95+
All-Oral Therapy
Direct-Acting
Antivirals
Slide credit: clinicaloptions.com
Nearly Everyone With HCV Can Now Be
Treated Successfully
Very high SVR rates; therapies highly tolerable
All-oral therapy for almost every pt
Treatment generally just 12 wks
![Page 8: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/8.jpg)
![Page 9: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/9.jpg)
Gerencia de Gestión de Negocios
Dirección General
Análisis de medicamentos
OSDE País
Acto médico y Compras
![Page 10: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/10.jpg)
Gerencia de Gestión de Negocios
Dirección General
El gasto médico total en OSDE del período jun-18 a may-19 fue de $93.560.126.421.
El gasto en medicamentos fue de $ 23.307.480.484, lo cual es un 25% del gasto total.
Apertura por Clase de costo
7%
25%
4%
24%
36%
4%
Composición por rubro de medicamentos
Medicamentos eninternación
Medicamentosoncológicos
Medicamentos HIV
MedicamentosFarmacia
Medicamentos porprovisión
![Page 11: Mesa redonda: Medicamentos de alto costo - Argentina · Mesa redonda: Medicamentos de alto costo. The Costs of Cancer Treatment. Growth in Cost of Oncology Therapeutics, US IQVIA,](https://reader034.vdocuments.site/reader034/viewer/2022042317/5f05b1687e708231d4143a95/html5/thumbnails/11.jpg)
Gerencia de Gestión de Negocios
Dirección General
El gasto médico total en OSDE del período jun-18 a may-19 fue de $93.560.126.421. un 25% de este
responde a medicamentos.
A continuación se muestran los indicadores por rubro:
Apertura por Clase de costo - Variaciones
Nota: recordar que cada período es desde junio del año anterior hasta mayo.
Rubro Gasto médico Pacientes Variación de precio
Medicamentos por provisión 8.315.827.175$ 483.596 67%
Medicamentos oncológicos 5.787.851.582$ 22.424 63%
Medicamentos Farmacia 5.521.888.029$ 1.891.445 52%
Medicamentos en internación 1.642.562.869$ 152.303 52%
Medicamentos HIV 1.050.812.877$ 5.871 78%
Medicamentos discapacidad 988.537.952$ 18.035 62%
Los pacientes en oncología representan un 5% de los pacientes de medicamentos por provisión, y el gasto es tan sólo un 30% menos.